Concepedia

Author

Timo Vogt

University Hospital BonnORCID

Also Known As

T Vogt, T. Vogt, Timo J Vogt, Timo J. Vogt, Timo Jakob Vogt, Timo Vogt, Vogt, Timo

34

Publications

477

Citations

11

H-Index

12

Concepts

All Affiliations

University Hospital BonnThe University of MelbournePeter Doherty InstituteUniversity of Bonn
TV

About

Timo Vogt is an author at University Hospital Bonn specializing in pathology, radiation oncology, and molecular diagnostics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

87

2

Immunology

1

1

87

3

Pathology

1

1

87

4

Immune Surveillance

1

1

87

5

Immunotherapy

1

1

87

Timo Vogt

×

12

Publications

453

Citations

11

H-Index

YearCitations

CTLA4 methylation predicts response to anti–PD-1 and anti–CTLA-4 immunotherapy in melanoma patients

Diane Goltz, Heidrun Gevensleben, Timo Vogt,

JCI Insight

2018

87

Molecular and immune correlates of TIM-3 (HAVCR2) and galectin 9 (LGALS9) mRNA expression and DNA methylation in melanoma

Tobias A.W. Holderried, Luka de Vos, Emma Bawden,

Clinical Epigenetics

2019

83

Molecular, clinicopathological, and immune correlates of LAG3 promoter DNA methylation in melanoma

Anne Fröhlich, Judith Sirokay, Simon Fietz,

EBioMedicine

2020

65

<i>PD-L1</i> (<i>CD274</i>) and <i>PD-L2</i> (<i>PDCD1LG2</i>) promoter methylation is associated with HPV infection and transcriptional repression in head and neck squamous cell carcinomas

Alina Franzen, Timo Vogt, Tim Müller,

Oncotarget

2017

58

Detailed analysis of adenosine A2a receptor (<i>ADORA2A</i>) and CD73 (5′-nucleotidase, ecto,<i>NT5E</i>) methylation and gene expression in head and neck squamous cell carcinoma patients

Timo Vogt, Heidrun Gevensleben, Jörn Dietrich,

OncoImmunology

2018

27

DNA methylation of indoleamine 2,3-dioxygenase 1 (IDO1) in head and neck squamous cell carcinomas correlates with IDO1 expression, HPV status, patients’ survival, immune cell infiltrates, mutational load, and interferon γ signature

Verena Sailer, Ulrike Sailer, Emma Bawden,

EBioMedicine

2019

27

DNA methylation regulates TIGIT expression within the melanoma microenvironment, is prognostic for overall survival, and predicts progression-free survival in patients treated with anti-PD-1 immunotherapy

Dennis Niebel, Anne Fröhlich, Romina Zarbl,

Clinical Epigenetics

2022

26

CTLA4 DNA methylation is associated with CTLA-4 expression and predicts response to immunotherapy in head and neck squamous cell carcinoma

Friederike Hoffmann, Alina Franzen, Luka de Vos,

Clinical Epigenetics

2023

23

Intragenic DNA methylation of PITX1 and the adjacent long non-coding RNA C5orf66-AS1 are prognostic biomarkers in patients with head and neck squamous cell carcinomas

Verena Sailer, Arthur Charpentier, Joern Dietrich,

PLoS ONE

2018

16

CTLA4, PD-1, PD-L1, PD-L2, TIM-3, TIGIT, and LAG3 DNA Methylation Is Associated With BAP1-Aberrancy, Transcriptional Activity, and Overall Survival in Uveal Melanoma

Luka de Vos, Tzaitel Maria Carrillo Cano, Romina Zarbl,

Journal of Immunotherapy

2022

16

Page 1